Akèy › Metiyè › Chemists › Boston, MA

Chemists nan Boston, MA: Salè H-1B

97 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Boston, MA. Salè baz medyàn ofri $125,500; mwatye mitan $93,815–$145,750.

Demann (LCA)97

Salè medyan ofri$125,500

Mwatye salè yo$93,815–$145,750

10yèm–90yèm pousantaj$79,082–$166,582

Pa nivo salè

Nivo revni	Salè medyan
Nivo I (antre)	$79,541
Nivo II (kalifye)	$95,130
Nivo III (eksperyans)	$121,462
Nivo IV (plen kompetans)	$152,513

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Anplwayè yo

Anplwayè	LCA	Salè medyan
Vertex Pharmaceuticals Incorporated	31	$119,413
Eli Lilly and Company	12	$150,348
Dana-Farber Cancer Institute	8	$102,300
Harvard University	7	$74,250
Northeastern University	7	$79,082
CRISPR Therapeutics, Inc.	4	$159,176
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP	3	$144,000
Verve Therapeutics, Inc.	2	$120,000
Atalanta Therapeutics, Inc.	2	$194,550
Nimbus Therapeutics, LLC	2	$215,000
PureTech Management, Inc	1	$150,000
Advent Technologies, Inc.	1	$74,000
Karuna Therapeutics, Inc.	1	$170,000
Brigham and Women's Hospital	1	$108,264
Entrada Therapeutics, Inc.	1	$92,500
Blastid, Inc	1	$115,000
Strand Therapeutics Inc.	1	$123,000
Seaport Therapeutics Inc	1	$190,000
Ratio Therapeutics, Inc.	1	$141,500
Nereid Therapeutics Incorporated	1	$134,000
Merck Research Laboratories Massachusetts, LLC	1	$128,800
pacDNA LLC	1	$140,000
Atea Pharmaceuticals, Inc.	1	$161,965
Vivtex Corporation	1	$106,000
Lenox Executive Search, LLC	1	$140,000
Pratt Pathology Associates, Inc. (TMCPO)	1	$200,000
FerroByte, Inc.	1	—
Cadence Design Systems, Inc.	1	$151,674
QuEra Computing Incorporated	1	$155,000

Tit travay

Pwonse H-1B nan Boston, MA →

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).